Sustainability Report

Overview

The report presents Imexpharm's 2019 sustainability performance under GRI, including consolidated revenue and employee totals, a newly established Sustainable Development Committee, extensive employee training, factory-level environmental disclosures, community programs and no reported work-related deaths.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services